GlassScriptPhysician profile
Melissa M Dimick
NPI 1700109824
$3,774.05
in general payments reported to CMS, 2019-2025
33 companies · $839 in 2025
The $839 reported for 2025 was more than what 85% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $362 · 2022: $835 · 2023: $1,036 · 2024: $703 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,482 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,482.12 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $407.99 | 2021-2024 | Aveir, Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $380.33 | 2021-2025 | Lifevest |
| Stryker Corporation | $333.16 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Amgen INC. | $322.27 | 2021-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $291.85 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $233.46 | 2021-2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $183.09 | 2022-2025 | Watchman Flx, Enroute Transcarotid Stent, Watchman Access System |
| Edwards Lifesciences Corporation | $160.02 | 2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $148.76 | 2023-2024 | |
| Impulse Dynamics (USA) INC. | $147.31 | 2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $141.09 | 2021-2024 | Andexxa, Wainua, Farxiga |
| Alnylam Pharmaceuticals INC. | $138.73 | 2023-2024 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $120.01 | 2022-2023 | Uptravi, Opsumit |
| Novo Nordisk INC | $107.41 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $66.18 | 2022-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $63.96 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $57.66 | 2023-2024 | Inpefa |
| Inari Medical, INC. | $50.90 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kestra Medical Technology Services, INC. | $42.35 | 2024 | Assure Wcd |
| Nuwellis, INC. | $41.83 | 2021 | |
| Vanda Pharmaceuticals INC. | $40.13 | 2022 | |
| Angiodynamics, INC. | $38.88 | 2025 | Alphavac |
| E.R. Squibb & Sons, L.L.C. | $37.75 | 2024-2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $36.28 | 2022-2023 | |
| Chiesi USA, INC. | $29.63 | 2023-2024 | Kengreal, Cleviprex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.76 | 2021 | |
| Daiichi Sankyo INC. | $23.67 | 2023 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $21.45 | 2024 | Evkeeza |
| Baxter Healthcare | $20.06 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Medtronic, INC. | $17.40 | 2022 | |
| Pharmacosmos Therapeutics INC. | $16.45 | 2024 | Monoferric |
| Altathera Pharmaceuticals LLC | $15.37 | 2023 | Sotalol Hydrochloride |
| Kiniksa Pharmaceuticals International, Plc | $14.86 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Dimick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.